« Back to Record
Citation APA

Rugo, H., Pritchard, K., Gnant, M., Noguchi, S., Piccart-Gebhart, M., Hortobagyi, G. N., Baselga, J., Perez, A., Geberth, M., Csöszi, T., Chouinard, E., Srimuninnimit, V., Puttawibul, P., Eakle, J., Feng, W., El-Hashimy, M., Taran, T., Bauly, H., & Burris, H. H. (2014). Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: Insights from BOLERO-2. Annals of oncology, 25(4), mdu009, 808-815. doi:10.1093/annonc/mdu009


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/195362

Rugo, H., Pritchard, K., Gnant, M., Noguchi, S., Piccart-Gebhart, M., Hortobagyi, G. N., Baselga, J., Perez, A., Geberth, M., Csöszi, T., Chouinard, E., Srimuninnimit, V., Puttawibul, P., Eakle, J., Feng, W., El-Hashimy, M., Taran, T., Bauly, H., & Burris, H. H. (2014). Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: Insights from BOLERO-2. Annals of oncology, 25(4), mdu009, 808-815. doi:10.1093/annonc/mdu009